RSS-Feed abonnieren
DOI: 10.1055/a-1663-8108
Mice Lacking PECAM-1 and Ceacam1 Have Enhanced Platelet Secretion and Thrombus Growth: Novel Link with PAR4
![](https://www.thieme-connect.de/media/10.1055-s-00035024/202206/lookinside/thumbnails/10-1055-a-1663-8108_200910-1.jpg)
Abstract
The Ig-ITIM bearing receptors, PECAM-1 and CEACAM1, have been shown net negative regulators of platelet–collagen interactions and hemiITAM signaling pathways. In this study, a double knockout (DKO) mouse was developed with deleted PECAM-1 and CEACAM1 to study their combined contribution in platelet activation by glycoprotein VI, C-type lectin-like receptor 2, protease activated receptor (PAR4), ADP purinergic receptors, and thromboxane receptor (TP) A2 pathways. In addition, their collective contribution was examined in thrombus formation under high shear and microvascular thrombosis using in vivo models. DKO platelets responded normally to ADP purinergic receptors and the TP A2 pathway. However, DKO platelets released significantly higher amounts of P-selectin compared with hyper-responsive Pecam-1−/− or Ceacam1−/− versus wild-type (WT) upon stimulation with collagen-related peptide or rhodocytin. In contrast, DKO platelets showed increased amounts of P-selectin exposure upon stimulation with PAR4 agonist peptide or thrombin but not Pecam-1−/− , Ceacam1−/− , or WT platelets. Blockade of phospholipase C (PLC) or Rho A kinase revealed that DKO platelets enhanced α-granule release via PAR4/Gαq/PLC signaling without crosstalk with Src/Syk or G12/13 signaling pathways. Severely delayed clot retraction in vitro was observed in DKO phenotype. The DKO model revealed a significant increase in thrombus formation compared with the hyper-responsive Ceacam1−/− or Pecam-1−/− versus WT phenotype. DKO platelets have similar glycoprotein surface expression compared with Pecam-1−/− , Ceacam1−/− , and WT platelets. This study demonstrates that PECAM-1 and CEACAM1 work in concert to negatively regulate hemiITAM signaling, platelet–collagen interactions, and PAR4 Gαq protein- coupled signaling pathways. Both PECAM-1 and CEACAM1 are required for negative regulation of platelet activation and microvascular thrombosis in vivo.
Author Contributions
F.A.K., F.A., G.D., and J.A. performed the experiments. G.B. and N.B. provided intellectual input and reviewed the paper; D.E.J. directed the research and wrote the manuscript.
Publikationsverlauf
Eingereicht: 01. Dezember 2020
Angenommen: 05. Oktober 2021
Accepted Manuscript online:
07. Oktober 2021
Artikel online veröffentlicht:
28. Dezember 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Coxon CH, Geer MJ, Senis YA. ITIM receptors: more than just inhibitors of platelet activation. Blood 2017; 129 (26) 3407-3418
- 2 Ribas G, Neville M, Wixon JL, Cheng J, Campbell RD. Genes encoding three new members of the leukocyte antigen 6 superfamily and a novel member of Ig superfamily, together with genes encoding the regulatory nuclear chloride ion channel protein (hRNCC) and an N omega-N omega-dimethylarginine dimethylaminohydrolase homologue, are found in a 30-kb segment of the MHC class III region. J Immunol 1999; 163 (01) 278-287
- 3 de Vet EC, Aguado B, Campbell RD. G6b, a novel immunoglobulin superfamily member encoded in the human major histocompatibility complex, interacts with SHP-1 and SHP-2. J Biol Chem 2001; 276 (45) 42070-42076
- 4 Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164 (10) 4991-4995
- 5 Patil S, Newman DK, Newman PJ. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 2001; 97 (06) 1727-1732
- 6 Dhanjal TS, Ross EA, Auger JM. et al. Minimal regulation of platelet activity by PECAM-1. Platelets 2007; 18 (01) 56-67
- 7 Jackson DE. The unfolding tale of PECAM-1. FEBS Lett 2003; 540 (1-3): 7-14
- 8 Wong C, Liu Y, Yip J. et al. CEACAM1 negatively regulates platelet-collagen interactions and thrombus growth in vitro and in vivo. Blood 2009; 113 (08) 1818-1828
- 9 Jones KL, Hughan SC, Dopheide SM, Farndale RW, Jackson SP, Jackson DE. Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions. Blood 2001; 98 (05) 1456-1463
- 10 Alshahrani MM, Yang E, Yip J. et al. CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. Blood 2014; 124 (15) 2431-2441
- 11 Jones CI, Garner SF, Moraes LA. et al; Bloodomics Consortium. PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways. FEBS Lett 2009; 583 (22) 3618-3624
- 12 Wee JL, Jackson DE. The Ig-ITIM superfamily member PECAM-1 regulates the “outside-in” signaling properties of integrin α(IIb)β3 in platelets. Blood 2005; 106 (12) 3816-3823
- 13 Alshahrani MM, Kyriacou RP, O'Malley CJ, Heinrich G, Najjar SM, Jackson DE. CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. Platelets 2016; 27 (08) 743-750
- 14 Yip J, Alshahrani M, Beauchemin N, Jackson DE. CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. Platelets 2016; 27 (02) 168-177
- 15 Schmoker AM, Perez Pearson LM, Cruz C. et al. Defining the TLT-1 interactome from resting and activated human platelets. J Proteomics 2020; 215: 103638
- 16 Mazharian A, Wang YJ, Mori J. et al. Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function. Sci Signal 2012; 5 (248) ra78
- 17 Kuriri FA, O'Malley CJ, Jackson DE. Molecular mechanisms of immunoreceptors in platelets. Thromb Res 2019; 176: 108-114
- 18 Washington AV, Gibot S, Acevedo I. et al. TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest 2009; 119 (06) 1489-1501
- 19 Gkaliagkousi E, Ferro A. Nitric oxide signalling in the regulation of cardiovascular and platelet function. Front Biosci 2011; 16: 1873-1897
- 20 Higgs EA, Higgs GA, Moncada S, Vane JR. Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. 1977. Br J Pharmacol 1997; 120 (4, Suppl): 439-443
- 21 Arachiche A, de la Fuente M, Nieman MT. Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets. PLoS One 2013; 8 (02) e55740-e55740
- 22 Cicmil M, Thomas JM, Leduc M, Bon C, Gibbins JM. Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets. Blood 2002; 99 (01) 137-144
- 23 Li S, Tarlac V, Hamilton JR. Using PAR4 inhibition as an anti-thrombotic approach: why, how, and when?. Int J Mol Sci 2019; 20 (22) 5629
- 24 Klages B, Brandt U, Simon MI, Schultz G, Offermanns S. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 1999; 144 (04) 745-754
- 25 Aslan JE, McCarty OJT. Rho GTPases in platelet function. J Thromb Haemost 2013; 11 (01) 35-46
- 26 Moers A, Nieswandt B, Massberg S. et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 2003; 9 (11) 1418-1422
- 27 Mehrbod M, Trisno S, Mofrad MR. On the activation of integrin αIIbβ3: outside-in and inside-out pathways. Biophys J 2013; 105 (06) 1304-1315
- 28 Sun D-S, Lo SJ, Lin C-H. et al. Calcium oscillation and phosphatidylinositol 3-kinase positively regulate integrin α(IIb)β3-mediated outside-in signaling. J Biomed Sci 2005; 12 (02) 321-333
- 29 Baade T, Paone C, Baldrich A, Hauck CR. Clustering of integrin β cytoplasmic domains triggers nascent adhesion formation and reveals a protozoan origin of the integrin-talin interaction. Sci Rep 2019; 9 (01) 5728
- 30 Hantgan R, Stahle M, Del Gaizo V. et al. αIIb's cytoplasmic domain is not required for ligand-induced clustering of integrin αIIbβ3. Biochimica et Biophysica Acta (BBA)-. Mol Cell Res 2001; 1540: 82-95
- 31 Moraes LA, Barrett NE, Jones CI. et al. Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells. J Thromb Haemost 2010; 8 (11) 2530-2541
- 32 Moraes LA, Vaiyapuri S, Sasikumar P. et al. Antithrombotic actions of statins involve PECAM-1 signaling. Blood 2013; 122 (18) 3188-3196
- 33 Vandendries ER, Hamilton JR, Coughlin SR, Furie B, Furie BC. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc Natl Acad Sci U S A 2007; 104 (01) 288-292
- 34 Kahn ML, Zheng Y-W, Huang W. et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394 (6694): 690-694
- 35 Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404 (6778): 609-613
- 36 Thibeault PE, LeSarge JC, Arends D. et al. Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4). J Biol Chem 2020; 295 (08) 2520-2540
- 37 Yeh JC, Otte LA, Frangos JA. Regulation of G protein-coupled receptor activities by the platelet-endothelial cell adhesion molecule, PECAM-1. Biochemistry 2008; 47 (34) 9029-9039
- 38 Rathore V, Stapleton MA, Hillery CA. et al. PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets. Blood 2003; 102 (10) 3658-3664